97 related articles for article (PubMed ID: 19383343)
1. Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.
Kousidou OCh; Berdiaki A; Kletsas D; Zafiropoulos A; Theocharis AD; Tzanakakis GN; Karamanos NK
Mol Oncol; 2008 Oct; 2(3):223-32. PubMed ID: 19383343
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.
Potier M; Karl M; Zheng F; Elliot SJ; Striker GE; Striker LJ
Am J Pathol; 2002 May; 160(5):1877-85. PubMed ID: 12000739
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma.
Motta JM; Hassan H; Ibrahim SA
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980680
[TBL] [Abstract][Full Text] [Related]
4. Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer.
Papakonstantinou E; Piperigkou Z; Karamanos NK; Zolota V
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077676
[TBL] [Abstract][Full Text] [Related]
5. Drivers and suppressors of triple-negative breast cancer.
Wu W; Warner M; Wang L; He WW; Zhao R; Guan X; Botero C; Huang B; Ion C; Coombes C; Gustafsson JA
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34389675
[TBL] [Abstract][Full Text] [Related]
6. Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1.
Buoso E; Masi M; Racchi M; Corsini E
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287384
[TBL] [Abstract][Full Text] [Related]
7. Effects of obesity on NK cells in a mouse model of postmenopausal breast cancer.
Spielmann J; Mattheis L; Jung JS; Rauße H; Glaß M; Bähr I; Quandt D; Oswald J; Kielstein H
Sci Rep; 2020 Nov; 10(1):20606. PubMed ID: 33244094
[TBL] [Abstract][Full Text] [Related]
8. EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin α
Gasca J; Flores ML; Jiménez-Guerrero R; Sáez ME; Barragán I; Ruíz-Borrego M; Tortolero M; Romero F; Sáez C; Japón MA
Cell Death Discov; 2020; 6():86. PubMed ID: 33014430
[TBL] [Abstract][Full Text] [Related]
9. Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors.
Tzanakakis G; Giatagana EM; Kuskov A; Berdiaki A; Tsatsakis AM; Neagu M; Nikitovic D
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847060
[TBL] [Abstract][Full Text] [Related]
10. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells.
Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L
Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484
[TBL] [Abstract][Full Text] [Related]
11. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2018 Sep; 109(9):2919-2936. PubMed ID: 29968393
[TBL] [Abstract][Full Text] [Related]
12. IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules.
Afratis NA; Bouris P; Skandalis SS; Multhaupt HA; Couchman JR; Theocharis AD; Karamanos NK
Sci Rep; 2017 Jan; 7():40138. PubMed ID: 28079144
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen Resistance: Emerging Molecular Targets.
Rondón-Lagos M; Villegas VE; Rangel N; Sánchez MC; Zaphiropoulos PG
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548161
[TBL] [Abstract][Full Text] [Related]
14. The complex nature of oestrogen signalling in breast cancer: enemy or ally?
Lipovka Y; Konhilas JP
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160081
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.
Shawky MS; Ricciardelli C; Lord M; Whitelock J; Ferro V; Britt K; Thompson EW
J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):121-31. PubMed ID: 26501889
[TBL] [Abstract][Full Text] [Related]
16. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.
Theocharis AD; Skandalis SS; Neill T; Multhaupt HA; Hubo M; Frey H; Gopal S; Gomes A; Afratis N; Lim HC; Couchman JR; Filmus J; Sanderson RD; Schaefer L; Iozzo RV; Karamanos NK
Biochim Biophys Acta; 2015 Apr; 1855(2):276-300. PubMed ID: 25829250
[TBL] [Abstract][Full Text] [Related]
17. The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.
Nikitovic D; Kouvidi K; Voudouri K; Berdiaki A; Karousou E; Passi A; Tzanakakis GN
Biomed Res Int; 2014; 2014():124321. PubMed ID: 25140302
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers.
Gürsoy M; Zeidán-Chuliá F; Könönen E; Moreira JC; Liukkonen J; Sorsa T; Gürsoy UK
OMICS; 2014 Sep; 18(9):582-90. PubMed ID: 24983467
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
